{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:43:22Z","timestamp":1786373002666,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>As the kidney transplant waiting list grows, the willingness of transplant centers to accept complex donors increases. Guidelines for the evaluation of living kidney donors exist but do not provide clear guidance when evaluating the complex donor. Although few transplant centers will approve donor candidates with impaired glucose tolerance and most, if not all, will deny candidates with diabetes, many will approve candidates with impaired fasting glucose (IFG). Furthermore, the demographic of living donors has changed in the past 10 years to increasingly include more nonwhite and Hispanic individuals who are at greater risk for future diabetes and hypertension. IFG may be more of a concern in potential donors whose nonwhite and Hispanic ethnicity already places them at greater risk. We review the definition of diabetes, diabetes prediction tools, and transplant guidelines for donor screening and exclusion as it pertains to impaired glucose metabolism, and additional ethnic and nonethnic factors to consider. We offer an algorithm to aid in evaluation of potential living donors with IFG in which ethnicity, age, and features of the metabolic syndrome play a role in the decision making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.03370411","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T21:42:28Z","timestamp":1311370948000},"page":"2054-2059","source":"Crossref","is-referenced-by-count":12,"title":["Should Living Kidney Donor Candidates with Impaired Fasting Glucose Donate?"],"prefix":"10.2215","volume":"6","author":[{"given":"Christine Buchek","family":"Vigneault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Stuart","family":"Asch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neera Kanhouwa","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Johnson","family":"Bia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20230811","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/01.TP.0000157343.27949.9F","article-title":"A report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and medical guidelines","volume":"79","author":"Delmonico","year":"2005","journal-title":"Transplantation"},{"key":"R2-37-20230811","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1600-6143.2008.02361.x","article-title":"Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers","volume":"8","author":"Reese","year":"2008","journal-title":"Am J Transplant"},{"key":"R5-37-20230811","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2215\/CJN.01510210","article-title":"The state of U.S. living kidney donors","volume":"5","author":"Davis","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-37-20230811","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00007890-199508270-00003","article-title":"Evaluation of living renal donors: The current practice of US transplant centers","volume":"60","author":"Bia","year":"1995","journal-title":"Transplantation"},{"key":"R7-37-20230811","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1600-6143.2007.01932.x","article-title":"The medical evaluation of living kidney donors: A survey of US transplant centers","volume":"7","author":"Mandelbrot","year":"2007","journal-title":"Am J Transplant"},{"key":"R8-37-20230811","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"R9-37-20230811","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"R10-37-20230811","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among living kidney donors","volume":"363","author":"Lentine","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-37-20230811","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"R13-37-20230811","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: Implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"R14-37-20230811","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: A practical tool to predict type 2 diabetes risk","volume":"26","author":"Lindstrom","year":"2003","journal-title":"Diabetes Care"},{"key":"R15-37-20230811","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/diacare.26.11.3093","article-title":"Archimedes: A trial-validated model of diabetes","volume":"26","author":"Eddy","year":"2003","journal-title":"Diabetes Care"},{"key":"R16-37-20230811","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dc08-0521","article-title":"Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models","volume":"31","author":"Stern","year":"2008","journal-title":"Diabetes Care"},{"key":"R17-37-20230811","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.ajkd.2007.08.022","article-title":"Evaluation of the potential living kidney donor","volume":"50","author":"Pham","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R18-37-20230811","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1111\/j.1440-1797.2009.01222.x","article-title":"Donors at risk: Impaired glucose tolerance. The CARI Guidelines","volume":"15","author":"Boudville","year":"2010","journal-title":"Nephrology"},{"key":"R19-37-20230811","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1503\/cmaj.080012","article-title":"Risk of development of diabetes mellitus after diagnosis of gestational diabetes","volume":"179","author":"Feig","year":"2008","journal-title":"CMAJ"},{"key":"R20-37-20230811","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R21-37-20230811","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2337\/diacare.26.11.3153","article-title":"The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study","volume":"26","author":"Lorenzo","year":"2003","journal-title":"Diabetes Care"},{"key":"R22-37-20230811","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"R23-37-20230811","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.109.887521","article-title":"Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men","volume":"121","author":"Arnlov","year":"2010","journal-title":"Circulation"},{"key":"R24-37-20230811","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/dc10-0955","article-title":"Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men","volume":"34","author":"Arnlov","year":"2011","journal-title":"Diabetes Care"},{"key":"R25-37-20230811","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/oby.2009.388","article-title":"Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: Results from large scale efficacy trials","volume":"17","author":"Horton","year":"2009","journal-title":"Obesity (Silver Spring"},{"key":"R26-37-20230811","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R29-37-20230811","first-page":"779","article-title":"Ethnic disparities in type 2 diabetes: Pathophysiology and implications for prevention and management","volume":"95: 774","author":"Dagogo-Jack","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"R30-37-20230811","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa0804883","article-title":"Long-term consequences of kidney donation","volume":"360","author":"Ibrahim","year":"2009","journal-title":"N Engl J Med"},{"key":"R31-37-20230811","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/TP.0b013e3181e6e79b","article-title":"Long-term medical outcomes among Aboriginal living kidney donors","volume":"90","author":"Storsley","year":"2010","journal-title":"Transplantation"},{"key":"R32-37-20230811","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"R33-37-20230811","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/01.tp.0000250728.73268.e3","article-title":"Incidence of end-stage renal disease among live kidney donors","volume":"82","author":"Fehrman-Ekholm","year":"2006","journal-title":"Transplantation"},{"key":"R34-37-20230811","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1073\/pnas.82.17.5963","article-title":"Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy","volume":"82","author":"Zatz","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-37-20230811","first-page":"1085","article-title":"Effect of unilateral nephrectomy on renal function of diabetic rats","volume":"19","author":"Lopes","year":"2004","journal-title":"Histol Histopathol"},{"key":"R36-37-20230811","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2337\/diab.35.9.1011","article-title":"Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats","volume":"35","author":"O'Donnell","year":"1986","journal-title":"Diabetes"},{"key":"R37-37-20230811","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diacare.28.10.2436","article-title":"Glycemic status and development of kidney disease: The Framingham Heart Study","volume":"28","author":"Fox","year":"2005","journal-title":"Diabetes Care"},{"key":"R38-37-20230811","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2337\/diacare.21.9.1521","article-title":"Urinary albumin excretion rate and glomerular filtration rate in single-kidney type 2 diabetic patients","volume":"21","author":"Silveiro","year":"1998","journal-title":"Diabetes Care"},{"key":"R39-37-20230811","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2337\/db07-1610","article-title":"Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients","volume":"57","author":"Chang","year":"2008","journal-title":"Diabetes"},{"key":"R40-37-20230811","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/TP.0b013e3181d9e17b","article-title":"The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: Analysis at a single Japanese center","volume":"89","author":"Okamoto","year":"2010","journal-title":"Transplantation"},{"key":"R41-37-20230811","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-6143.2009.02944.x","article-title":"Diabetes after kidney donation","volume":"10","author":"Ibrahim","year":"2010","journal-title":"Am J Transplant"},{"key":"R42-37-20230811","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/S0002-8703(99)70037-2","article-title":"Diabetes and ischemic heart disease","volume":"138","author":"McGuire","year":"1999","journal-title":"Am Heart J"},{"key":"R43-37-20230811","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archinte.167.11.1122","article-title":"Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP)","volume":"167","author":"McCullough","year":"2007","journal-title":"Arch Intern Med"},{"key":"R44-37-20230811","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/TP.0b013e31817ba9e3","article-title":"Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada","volume":"86","author":"Garg","year":"2008","journal-title":"Transplantation"},{"key":"R45-37-20230811","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/TP.0b013e3181c1e156","article-title":"A study of renal outcomes in African American living kidney donors","volume":"88","author":"Nogueira","year":"2009","journal-title":"Transplantation"},{"key":"R47-37-20230811","first-page":"1566","article-title":"Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Four-year results of the Look AHEAD trial","volume":"170","author":"Wing","year":"2010","journal-title":"Arch Intern Med"},{"key":"R48-37-20230811","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2215\/CJN.02740409","article-title":"The science of Stewardship: Due diligence for kidney donors and kidney function in living kidney donation\u2014Evaluation, determinants, and implications for outcomes","volume":"4","author":"Poggio","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201108000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:03Z","timestamp":1786369263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201108000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03370411","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}